Personalized blood test pinpoints early breast cancer in preliminary study

Personalized blood test pinpoints early breast cancer in preliminary study

A new method for capturing circulating tumor DNA in the bloodstream underpins a highly precise blood test for tracking the early progression of breast cancer—which its developers say could be up to 100 times more sensitive than current tests.

Sourced through Scoop.it from: www.fiercebiotech.com

Who We Are

Omnica Corporation is a privately-held design, engineering, and medical product development firm located in Irvine, California. The 28-person company is staffed with full-time employees and has been in operation since 1984. Our speciality is custom product development for the medical industry and industrial fields.

Our expertise is developing complex medical devices.Technical personnel at Omnica includes designers, mechanical engineers, electronic and software engineers, advanced R&D specialists, regulatory staff (for FDA documentation), machinists and model makers.

Learn MoreOmnica Corporation

Leave a Reply

Your email address will not be published. Required fields are marked *